Sanofi | GJELD

Debt Endring Dato
AbbVie USD 74B 13.26B 2024-03
Amgen USD 64.02B 593M 2024-03
AstraZeneca USD 34.55B 5.93B 2024-03
Bristol-Myers Squibb USD 57.41B 17.64B 2024-03
Canopy Growth CAD 668M 25.27M 2024-03
Catalent USD 4.99B 15M 2024-03
Corcept Therapeutics USD 76K 76K 2024-03
Drreddys Laboratories INR 19.85B 6.62B 2023-12
Eli Lilly USD 26.21B 6.04B 2024-03
Galapagos EUR 7.98M 1.62M 2024-03
Genmab DKK 1.01B 240M 2024-03
GlaxoSmithKline GBP 17.77B 246M 2024-03
Glaxosmithkline GBP 17.77B 246M 2024-03
J&J USD 33.63B 3.71B 2024-03
Merck USD 34.22B 640M 2024-03
Novartis USD 27.28B 936M 2024-03
Novartis USD 27.28B 936M 2024-03
Pacira USD 581.78M 59.34M 2024-03
Perrigo USD 4.07B 7.9M 2024-03
Pfizer USD 68.71B 5.11B 2024-03
Prestige Brands USD 1.14B 62.07M 2024-03
Roche Holding CHF 29.21B 3.82B 2023-12
Supernus Pharmaceuticals USD 42.13M 438.74M 2024-03
UCB EUR 3.04B 142M 2023-12
Zoetis USD 6.77B 203M 2024-03



Sanofi GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.